Sign in

CIK 0001840233 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Xilio Therapeutics, Inc.

Sign in to watch
Ticker
XLO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851623397
Phone
617-833-1027
Business address
828 WINTER STREET, WALTHAM, MA, 02451
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 4 Insider Changes in Ownership
  4. 4 Insider Changes in Ownership
  5. 8-K Event Executive or director change · Shareholder vote results
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. 8-K Event Regulation FD disclosure
  11. DEF 14A Proxy Proxy Statement
  12. PRE 14A Proxy Proxy Statement (Preliminary)
  13. 8-K Event Delisting notice
  14. 8-K Event Other events
  15. 8-K Event Delisting notice
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. 10-Q Report Quarterly Report
  19. 8-K Event Results of operations
  20. 4 Insider Changes in Ownership

Page 4 of 19 · 361 filings